Companies: 10,795·Total market cap: $144.5T

Roivant Sciences Ltd.

Roivant Sciences Ltd.

ROIVNASDAQHealthcare● Active

$28.58

$-0.95(-3.22%)

Market Cap$20.6B

P/E Ratio—

52W High$32.793

52W Low$10.705

Avg Volume5.8M

Open$29.51

Beta1.14

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Roivant Sciences Ltd.（ROIV）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · ROIV · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-0.45Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)$8.3MFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding693.9MShares outstanding history

Next EarningsAug 10, 2026Est.Earnings history

探索 Roivant Sciences Ltd. 数据

分析师预测$37 · Buy

股息不分红

营收$8.3M-71.57%

盈利EPS $-0.43-79.17%

财务快照

FY 2026Revenue$8.3M▼ 71.57% YoY

202420252026

FY 2026Net Income-$299.8M▼ 74.30% YoY

202420252026

FY 2026EPS$-0.43▼ 79.17% YoY

202420252026

TTM:Revenue: $8.3MNet Income: -$299.8MEPS: $-0.45View income statement →

分析师评级与目标价

Buy15 位分析师

Strong Buy

0

Buy

14

Hold

1

Sell

0

Strong Sell

0

12-Month Price Target

$30.00Low

$28.58Current

$37.17Avg Target上涨空间 30.06%

$42.00High

合计: 15 · 买入占比: 93.3%

根据过去 3 个月内 15 位华尔街分析师，ROIV 共识评级为 Buy，12 个月平均目标价 $37.17 （较现价 $28.58 上涨空间 30.06%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Roivant Sciences Ltd.

$28.58-3.22%$20.6B #2

Ascendis Pharma A/S

$210.45-3.83%$13.0B #3

BridgeBio Pharma, Inc.

$67.61+0.42%$13.2B #4

Exact Sciences Corporation

$104.91+0.00%$20.0B #5

Ionis Pharmaceuticals, Inc.

$74.48-0.87%$12.3B #6

Jazz Pharmaceuticals plc

$238.57-0.62%$15.0B

股票表现

1D-3.22%

1W+1.03%

1M+0.07%

3M-0.69%

YTD+31.71%

1Y+157.94%

5Y+189.86%

关于 Roivant Sciences Ltd.

CEOMatthew Gline

IPO DateDec 8, 2020

Employees908

CountryGB

Websiteroivant.com

Roivant Sciences Ltd. a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, …

Biotechnology HealthcareNASDAQGB

关于股票概览与关键数据

Roivant Sciences Ltd.（ROIV）是 Biotechnology 行业的 Healthcare 类公司，于 Dec 8, 2020 在 NASDAQ 上市。截至最近交易日，ROIV 股价为 $28.58，市值约为 $20.6B。过去12个月累计回报 +157.94%，年初至今回报 +31.71%。

根据 15 位华尔街分析师，Roivant Sciences Ltd. 股票共识评级为Buy，12个月平均目标价为 $37.17。2026 财年 Roivant Sciences Ltd. 营收 $8.3M，净利润 -$299.8M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Roivant Sciences Ltd.（ROIV）股价为 $28.58，在 NASDAQ 上市，52周区间为 $10.71 – $32.79。

ROIV 最新股价ROIV quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议